Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
EQRx, Inc. - Common Stock
(NQ:
EQRX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 8, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about EQRx, Inc. - Common Stock
< Previous
1
2
3
Next >
EQRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of EQRx, Inc. - EQRX
October 06, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
EQRX Shareholder Investigation: Robbins LLP Reminds Shareholders it is Investigating EQRx, Inc. on behalf of Shareholders
September 27, 2023
From
Robbins LLP
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Capri Holdings Limited (NYSE – CPRI), Avid® (Nasdaq - AVID), EQRx, Inc. (Nasdaq - EQRX)
August 10, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Earnings Outlook For EQRx
May 05, 2023
Via
Benzinga
Why EQRx Shares Dropped 28.62% on Thursday
November 10, 2022
The company suspended trials for one of its lead therapies.
Via
The Motley Fool
EQRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of EQRx, Inc. - EQRX
August 02, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 01, 2023
Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 01, 2023
Via
Benzinga
Revolution Medicines To Acquire EQRx In All-Stock Transaction To Gain Over $1B In Additional Capital
August 01, 2023
Revolution Medicines Inc (NASDAQ: RVMD) has agreed to acquire EQRx Inc (NASDAQ: EQRX) in an all-stock transaction intended to add more than $1 billion in net cash to
Via
Benzinga
Caterpillar, Oshkosh, AudioCodes And Other Big Stocks Moving Higher On Tuesday
August 01, 2023
U.S. stocks traded lower, with the Nasdaq Composite falling around 70 points on Tuesday. Here are some big stocks recording gains in today’s session. American Superconductor Corporation (NASDAQ: AMSC)...
Via
Benzinga
EQRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of EQRx, Inc. Is Fair to Shareholders
August 01, 2023
From
Halper Sadeh LLC
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 01, 2023
Via
Benzinga
Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional Capital
August 01, 2023
From
Revolution Medicines, Inc.; EQRx, Inc.
Via
GlobeNewswire
Week In Review: BlissBio Announces Potential $2 Billion Deal With Eisai For HER2 ADC
May 13, 2023
Bliss Biopharma may out-license global rights for its HER2 ADC to Eisai Pharma in a deal with a potential value of $2 billion. Also, Junshi Bio out-licensed regional rights for its anti-PD-1 mAb to Dr....
Via
Talk Markets
EQRx Announces Massive Strategic Reset, Slashes Pipeline & Workforce
May 09, 2023
EQRx Inc (NASDAQ: EQRX) will lay off 170 people and incur non-recurring costs of approximately $45 - $55 million for wind down, termination,
Via
Benzinga
EQRx Resets to Focus on Clinically Differentiated Medicines, Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial Results
May 08, 2023
From
EQRx, Inc.
Via
GlobeNewswire
EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023
April 27, 2023
From
EQRx, Inc.
Via
GlobeNewswire
EQRx, Inc. (EQRX) Shareholder Investigation: Robbins LLP is Investigating EQRX, Inc. on behalf of Shareholders
April 21, 2023
From
Robbins LLP
Via
Business Wire
EQRx Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Progress
February 23, 2023
From
EQRx, Inc.
Via
GlobeNewswire
EQRx to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
EQRx, Inc.
Via
GlobeNewswire
EQRx Announces Acceptance of Marketing Authorization Application by the UK’s Medicines and Healthcare Products Regulatory Agency for Sugemalimab in Metastatic Non-small Cell Lung Cancer
December 19, 2022
From
EQRx, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
December 14, 2022
On Wednesday, 115 stocks hit new 52-week lows.
Via
Benzinga
EQRx Announces Acceptance of Marketing Authorization Application by the European Medicines Agency for Aumolertinib in EGFR-Mutated Non-small Cell Lung Cancer
December 02, 2022
From
EQRx, Inc.
Via
GlobeNewswire
Week In Review: Insilico Signs Six-Drug Discovery Deal With Sanofi Worth Up To $1.2 Billion
November 12, 2022
Insilico Medicine signed a six-drug research collaboration with Sanofi that could be worth up to $1.2 billion. Insilico will receive up to $21.5 million in upfront and target nomination fees for each...
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2022
November 11, 2022
Upgrades
Via
Benzinga
BP To Rally Around 22%? Plus This Analyst Predicts $47 For YETI
November 11, 2022
Piper Sandler boosted the price target on BP p.l.c. (NYSE: BP) from $37 to $40. BP shares rose 1.9% to close at $32.95 on Thursday.
Via
Benzinga
Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday's Mid-Day Session
November 10, 2022
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's...
Via
Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
November 11, 2022
Gainers
Via
Benzinga
Cano Health, Vacasa, Organogenesis, And Some Other Big Stocks Moving Lower On Thursday
November 10, 2022
U.S. stocks traded higher, with the Nasdaq surging more than 500 points on Thursday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
EQRx Provides Portfolio and U.S. Commercial Strategy Updates; Reports Third Quarter 2022 Financial Results
November 10, 2022
From
EQRx, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.